These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38838436)

  • 1. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
    Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
    Transl Oncol; 2024 Aug; 46():102018. PubMed ID: 38838436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
    Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
    Zhang Z; Mei Y; Hou M
    Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.
    Huang S; Jin M; Lan X; Wu JL; Zhang Z; Zhao J; Li Y
    J Cancer; 2022; 13(8):2662-2672. PubMed ID: 35711823
    [No Abstract]   [Full Text] [Related]  

  • 7. The RNA m6A writer RBM15 contributes to the progression of esophageal squamous cell carcinoma by regulating miR-3605-5p/KRT4 pathway.
    Wang H
    Heliyon; 2024 Jan; 10(2):e24459. PubMed ID: 38312624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
    Wang H; Li C; Wei Q; Zhang E; Yang Y; Sha L; Wang D
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38429603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
    Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory mechanism of RNA binding motif protein 15-mediated N
    Chen J
    Environ Toxicol; 2023 Nov; 38(11):2545-2559. PubMed ID: 37471637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
    Wang R; Tan W
    Crit Rev Eukaryot Gene Expr; 2024; 34(5):15-29. PubMed ID: 38842201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
    Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
    Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing m
    Huang Y; Lv Y; Yang B; Zhang S; Bixia Liu ; Zhang C; Hu W; Jiang L; Chen C; Ji D; Xiong C; Liang Y; Liu M; Ying X; Ji W
    Heliyon; 2024 Apr; 10(7):e28165. PubMed ID: 38560117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
    Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
    Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma.
    Zhao Z; Ju Q; Ji J; Li Y; Zhao Y
    Front Mol Biosci; 2022; 9():842833. PubMed ID: 35223996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
    Fu M; Zhou B; Shi N; Dong R; Chen Y
    Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
    Rong L; Xu Y; Zhang K; Jin L; Liu X
    Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.
    Qin Y; Wu S; Zhang F; Zhou X; You C; Tan F
    Environ Toxicol; 2023 Nov; 38(11):2772-2782. PubMed ID: 37551785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.